晨間新聞

市場策略解密 - 瑞訊分析師

Akzo Nobel to Sell Southeast Asia Decorative Paints Business

作者 Igor JOVICIC
Oct 5, 2026
Akzo Nobel AKZA has agreed to sell its decorative paints business in Southeast Asia to Nippon Paint 4612 at an enterprise value of $1.35 billion. The Dutch paint company said Monday that net cash proceeds after taxes and minority partners are expected to be about $1 billion.

Nike Plans a Smaller Company as Sales Slide Deepens

作者 Igor JOVICIC
Oct 2, 2026
Nike NKE is planning to be a smaller company. After two straight quarters of falling revenue, Nike said it expects sales to keep declining this fiscal year and it will shrink its operations, cut jobs and merge regional businesses to adjust. “This work will result in fewer roles across Nike,” Chief Executive Elliott Hill wrote in a memo to employees.

Micron Profit, Revenue Surge as Memory Crunch Looks to Last Through 2028

作者 Stefano GIANTI
Oct 1, 2026
Micron MU Technology profit and revenue surged in the fiscal fourth quarter, as the company said the shortage of memory chips that has propelled its explosive growth in the past year shows no signs of slowing down. “Industry demand has strengthened since our last earnings call, and we expect memory and storage supply demand conditions to be much tighter in fiscal 2027 and 2028 than they were in 2026,” Chief Executive Sanjay Mehrotra said on a Wednesday call with analysts. Mehrotra’s comments come as investors have debated the durability of the memory shortage that has fueled Micron’s blowout earnings.

Oura Postpones IPO Over Market Uncertainty

作者 Igor JOVICIC
Sep 30, 2026
Smart-ring maker Oura said it was delaying its previously announced initial public offering due to market uncertainty. The San Francisco-based company, which was expected to fetch a valuation well above the $11 billion achieved in a funding round last year, said Tuesday it was postponing its listing “despite strong demand, due to uncertainty in the IPO market.” Oura made its IPO paperwork public earlier this month. It said the issue had attracted strong investor demand, but that the timing wasn’t right. The company was aiming to list on the Nasdaq as soon as this month.

AMD to Acquire World Labs for $8.2 Billion

作者 Igor JOVICIC
Sep 29, 2026
Advanced Micro Devices AMD agreed to acquire artificial-intelligence research firm World Labs in an all-stock deal valued at about $8.2 billion, an acquisition that reflects chip makers’ ambitions to control more of the AI stack. AMD, a semiconductor company that recently touched a $1 trillion valuation, said the deal would bring leading AI research and development talent and help the company develop better AI hardware, software and systems, especially in the growing field of physical AI and robotics. World Labs focuses on spatially intelligent AI models that can generate and simulate interactive 3-D environments.

Chemicals Giant BASF Moves for German Rival Evonik

作者 Stefano GIANTI
Sep 28, 2026
German chemicals producer BASF BAS said it entered initial talks over a takeover of smaller peer Evonik, a tie-up that would bolster BASF’s dominant position in Europe’s chemicals industry.

Anthropic to Pay Akamai Technologies $11.6 Billion for Cloud Services

作者 Stefano GIANTI
Sep 25, 2026
Anthropic will pay Akamai Technologies AKAM at least $11.6 billion to use its cloud infrastructure and software for over seven years in an expansion of the partnership between the two companies.

OpenAI Agent Hacked Australian Government Website

作者 Stefano GIANTI
Sep 24, 2026
An OpenAI agent infiltrated a government-services website in Australia this summer, Prime Minister Anthony Albanese said Wednesday at the United Nations meeting in New York.

Meta’s New AI Agent Is an Instant Hit—and the Backlash Has Already Begun

作者 Stefano GIANTI
Sep 23, 2026
Meta Platforms (-0.6%) appears to have a hit AI product on its hands, but the company’s path to ultimate domination in this next chapter of consumer AI use is anything but assured. Two weeks ago, Meta launched a new, easy-to-use personal AI agent called Muse. The app, which is how users access the agent, has been sitting at No. 1 on Apple’s U.S.

Roche's Eye Drug Susvimo Obtains EU Approval

作者 Igor JOVICIC
Sep 22, 2026
Roche will be able to market its eye medication Susvimo in the European Union. As the Swiss pharmaceutical company announced, the European Commission has granted approval. Susvimo is a treatment for neovascular age-related macular degeneration.
Switzerland

源自瑞士匠心設計

小心風險

在外匯交易平台上交易槓桿產品,例如外匯,現貨金屬和差價合約,都會因槓桿效應而面臨重大的虧損風險,因而並不適合所有投資者。在開立瑞訊之交易帳戶前,請考慮個人經驗水平、投資目標、資產、收入和可承擔之風險水平。理論上,虧損是可以無上限,如果帳戶餘額低於所需保證金水平,您有可能被追加資金,因此您不應該以自己無法承受虧損的資金進行交易,即您不應借入資金或以個人或家庭生活所急需或必要的資金進行投機、投資或對沖。過去12 個月,68.22%的零售投資者在交易差價合約時出現虧損、在平倉時損失全部保證金或平倉後帳戶出現負值。您必須清楚了解外匯交易中所有相關風險,如果有任何疑問時,應及時向獨立財務顧問尋求建議。如需更多資料,包括槓桿的影響、保證金交易的操作以及交易對手和市場風險,請參閱我們的外匯和差價合約風險披揭露。本網頁之內容包含市場推廣訊息,內容並沒有提交亦沒有得到相關監管機構之批核。

AI 生成的內容

我們網站上的一些視覺內容是使用人工智慧 (AI) 應用程式產生和/或增強的。但是,所有內容都經過徹底的人工審查和核准,以確保其準確性、相關性,並符合我們使用者和客戶的需求。